Document Detail


Nevirapine misinformation: will it kill?
MedLine Citation:
PMID:  15892199     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Three Associated Press (AP) reports in mid-December 2004 created widespread doubts about nevirapine (NVP), the critically important drug that can prevent HIV in many of the 1,800 babies infected every day by their mothers in childbirth. The media allegations that circulated around the world grew out of a bitter personal and personnel dispute between two employees at the US National Institutes of Health (NIH) about the conduct of the HIVNET 012 trial in Uganda from 1997 to 1999. No new information was released about NVP; indeed, following publication of the AP reports, physicians know that NVP still has the same risks and benefits as before. But many experts fear that the emotions stirred by the misinformation disseminated worldwide will result in many HIV-positive mothers receiving no treatment and unnecessarily infecting their children with HIV. This article offers background that has been missing in many news reports.
Authors:
John S James
Related Documents :
15892199 - Nevirapine misinformation: will it kill?
4501839 - Screening for transmission of hepatitis within a liver unit.
19730349 - Breastfeeding with maternal antiretroviral therapy or formula feeding to prevent hiv po...
12287809 - Update -- aids treatment and epidemiology.
16511429 - Enfurvitide prevents vertical transmission of multidrug-resistant hiv-1 in pregnancy bu...
17095329 - Hiv-specific secretory iga in breast milk of hiv-positive mothers is not associated wit...
15566499 - A primer on the molecular virology of hepatitis c.
17570169 - Reductionist and system approaches to study the role of infection in preterm labor and ...
12000599 - Management of viral hepatitis b.
Publication Detail:
Type:  Newspaper Article    
Journal Detail:
Title:  IAPAC monthly     Volume:  10     ISSN:  1545-1089     ISO Abbreviation:  IAPAC Mon     Publication Date:  2004 Dec 
Date Detail:
Created Date:  2005-05-02     Completed Date:  2005-05-26     Revised Date:  2008-11-21    
Medline Journal Info:
Nlm Unique ID:  101087241     Medline TA:  IAPAC Mon     Country:  United States    
Other Details:
Languages:  eng     Pagination:  450-4     Citation Subset:  X    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Female
HIV Infections / complications,  prevention & control,  transmission*
Humans
Infant, Newborn
Infectious Disease Transmission, Vertical / prevention & control*
Nevirapine / adverse effects*
Pregnancy
Pregnancy Complications, Infectious / prevention & control*
Reverse Transcriptase Inhibitors / adverse effects*
Chemical
Reg. No./Substance:
0/Reverse Transcriptase Inhibitors; 129618-40-2/Nevirapine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  APC is a component of an organizing template for cortical microtubule networks.
Next Document:  Dental photography systems: required features for equipment selection.